These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 30177073)

  • 1. Creating biobanks in low and middle-income countries to improve knowledge - The PREPARE initiative.
    De Oliveira L; Dias MAB; Jeyabalan A; Payne B; Redman CW; Magee L; Poston L; Chappell L; Seed P; von Dadelszen P; Roberts JM
    Pregnancy Hypertens; 2018 Jul; 13():62-64. PubMed ID: 30177073
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The International Federation of Gynecology and Obstetrics (FIGO) initiative on pre-eclampsia: A pragmatic guide for first-trimester screening and prevention.
    Poon LC; Shennan A; Hyett JA; Kapur A; Hadar E; Divakar H; McAuliffe F; da Silva Costa F; von Dadelszen P; McIntyre HD; Kihara AB; Di Renzo GC; Romero R; D'Alton M; Berghella V; Nicolaides KH; Hod M
    Int J Gynaecol Obstet; 2019 May; 145 Suppl 1(Suppl 1):1-33. PubMed ID: 31111484
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pre-eclampsia in low and middle income countries.
    Firoz T; Sanghvi H; Merialdi M; von Dadelszen P
    Best Pract Res Clin Obstet Gynaecol; 2011 Aug; 25(4):537-48. PubMed ID: 21592865
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Maternal mortality from preeclampsia/eclampsia.
    Ghulmiyyah L; Sibai B
    Semin Perinatol; 2012 Feb; 36(1):56-9. PubMed ID: 22280867
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The use of angiogenic biomarkers in maternal blood to identify which SGA fetuses will require a preterm delivery and mothers who will develop pre-eclampsia.
    Chaiworapongsa T; Romero R; Whitten AE; Korzeniewski SJ; Chaemsaithong P; Hernandez-Andrade E; Yeo L; Hassan SS
    J Matern Fetal Neonatal Med; 2016; 29(8):1214-28. PubMed ID: 26303962
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reducing maternal mortality from preeclampsia and eclampsia in low-resource countries--what should work?
    Goldenberg RL; Jones B; Griffin JB; Rouse DJ; Kamath-Rayne BD; Trivedi N; McClure EM
    Acta Obstet Gynecol Scand; 2015 Feb; 94(2):148-55. PubMed ID: 25353716
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PREPARE: protocol for a stepped wedge trial to evaluate whether a risk stratification model can reduce preterm deliveries among women with suspected or confirmed preterm pre-eclampsia.
    Dias MAB; De Oliveira L; Jeyabalan A; Payne B; Redman CW; Magee L; Poston L; Chappell L; Seed P; von Dadelszen P; Roberts JM;
    BMC Pregnancy Childbirth; 2019 Oct; 19(1):343. PubMed ID: 31590640
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prediction of pre-eclampsia-related complications in women with suspected or confirmed pre-eclampsia: development and internal validation of clinical prediction model.
    Saleh L; Alblas MM; Nieboer D; Neuman RI; Vergouwe Y; Brussé IA; Duvekot JJ; Steyerberg EW; Versendaal HJ; Danser AHJ; Meiracker AHVD; Verdonk K; Visser W
    Ultrasound Obstet Gynecol; 2021 Nov; 58(5):698-704. PubMed ID: 33030757
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lessons for low-income regions following the reduction in hypertension-related maternal mortality in high-income countries.
    Goldenberg RL; McClure EM; Macguire ER; Kamath BD; Jobe AH
    Int J Gynaecol Obstet; 2011 May; 113(2):91-5. PubMed ID: 21349517
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Significance of pre-hospital care to reduce the morbidity of eclampsia in rural Zambia.
    Miyoshi Y; Matsubara K; Takata N; Oka Y
    Pregnancy Hypertens; 2019 Jul; 17():100-103. PubMed ID: 31487623
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ASPRE trial: risk factors for development of preterm pre-eclampsia despite aspirin prophylaxis.
    Shen L; Martinez-Portilla RJ; Rolnik DL; Poon LC
    Ultrasound Obstet Gynecol; 2021 Oct; 58(4):546-552. PubMed ID: 33998099
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PROVE-Pre-Eclampsia Obstetric Adverse Events: Establishment of a Biobank and Database for Pre-Eclampsia.
    Bergman L; Bergman K; Langenegger E; Moodley A; Griffith-Richards S; Wikström J; Hall D; Joubert L; Herbst P; Schell S; van Veen T; Belfort M; Tong SYC; Walker S; Hastie R; Cluver C
    Cells; 2021 Apr; 10(4):. PubMed ID: 33924230
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Screening for pre-eclampsia at 11-13 weeks' gestation: use of pregnancy-associated plasma protein-A, placental growth factor or both.
    Mazer Zumaeta A; Wright A; Syngelaki A; Maritsa VA; Da Silva AB; Nicolaides KH
    Ultrasound Obstet Gynecol; 2020 Sep; 56(3):400-407. PubMed ID: 32441401
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preeclampsia in low and middle income countries-health services lessons learned from the PRE-EMPT (PRE-Eclampsia-Eclampsia Monitoring, Prevention and Treatment) project.
    von Dadelszen P; Firoz T; Donnay F; Gordon R; Justus Hofmeyr G; Lalani S; Payne BA; Roberts JM; Teela KC; Vidler M; Sawchuck D; Magee LA
    J Obstet Gynaecol Can; 2012 Oct; 34(10):917-926. PubMed ID: 23067947
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Screening and management of pre-eclampsia and eclampsia in antenatal and labor and delivery services: findings from cross-sectional observation studies in six sub-Saharan African countries.
    Rawlins B; Plotkin M; Rakotovao JP; Getachew A; Vaz M; Ricca J; Lynam P; Kagema F; Gomez P
    BMC Pregnancy Childbirth; 2018 Aug; 18(1):346. PubMed ID: 30139342
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pre-eclampsia, eclampsia and adverse maternal and perinatal outcomes: a secondary analysis of the World Health Organization Multicountry Survey on Maternal and Newborn Health.
    Abalos E; Cuesta C; Carroli G; Qureshi Z; Widmer M; Vogel JP; Souza JP;
    BJOG; 2014 Mar; 121 Suppl 1():14-24. PubMed ID: 24641531
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The WHO antenatal care randomised controlled trial: rationale and study design.
    Villar J; Bakketeig L; Donner A; al-Mazrou Y; Ba'aqeel H; Belizán JM; Carroli G; Farnot U; Lumbiganon P; Piaggio G; Berendes H
    Paediatr Perinat Epidemiol; 1998 Oct; 12 Suppl 2():27-58. PubMed ID: 9805722
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of diagnostic accuracy of early screening for pre-eclampsia by NICE guidelines and a method combining maternal factors and biomarkers: results of SPREE.
    Tan MY; Wright D; Syngelaki A; Akolekar R; Cicero S; Janga D; Singh M; Greco E; Wright A; Maclagan K; Poon LC; Nicolaides KH
    Ultrasound Obstet Gynecol; 2018 Jun; 51(6):743-750. PubMed ID: 29536574
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Competing-risks model in screening for pre-eclampsia by maternal factors and biomarkers at 35-37 weeks' gestation.
    Andrietti S; Silva M; Wright A; Wright D; Nicolaides KH
    Ultrasound Obstet Gynecol; 2016 Jul; 48(1):72-9. PubMed ID: 26566592
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Competing risks model in screening for preeclampsia by maternal factors and biomarkers at 30-34 weeks' gestation.
    Tsiakkas A; Saiid Y; Wright A; Wright D; Nicolaides KH
    Am J Obstet Gynecol; 2016 Jul; 215(1):87.e1-87.e17. PubMed ID: 26875953
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.